alexa TRAMADOL®.......Beyond its Beneficial Effects
ISSN: 2161-0495

Journal of Clinical Toxicology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

TRAMADOL®.......Beyond its Beneficial Effects

A. Salmi*
Department of Medical and Surgical Emergencies, University Hospital Center Mustapha (Pr.M.Guerinik), Algiers, Algeria
*Corresponding Author : Amine Salmi
Department of Medical and Surgical Emergencies
University Hospital Center Mustapha (Pr.M.Guerinik), Algiers, Algeria
Tel: 0663503399
E-mail: [email protected]
Received: December 28, 2015 Accepted: February 06, 2016 Published: February 15, 2016
Citation: Salmi A (2016) TRAMADOL®.......Beyond its Beneficial Effects. J Clin Toxicol 6:282. doi:10.4172/2161-0495.1000282
Copyright: © 2016 Salmi A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Tramadol® (analgesic of the landing 2) is a centrally acting analgesic with a dual mode of action. Its analgesic efficacy is attributed to its partial affinity for the (μ) mu-opiate receptor and its inhibition of noradrenaline and serotonin reuptake. Acting in a synergistic manner and being more efficacious, Tramadol® is used worldwide for the treatment of moderate to severe acute or chronic pain. If psychotropics are not an exceptional one because of SIADH (syndrome Inappropriate secretion of antidiuretic hormone), analgesics are not usually. This is the case of Tramadol®. We report on this observation the case of a 22 year old patient hospitalized for poisoning Tramadol®, having presented, hyponatremia, hypoglycemia, rhabdomyolyse and left cardiac decompensation.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version